Your browser doesn't support javascript.
loading
High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.
Kim, Sehui; Nam, Soo Jeong; Park, Changhee; Kwon, Dohee; Yim, Jeemin; Song, Seung Geun; Ock, Chan-Young; Kim, Young A; Park, Sung Hye; Kim, Tae Min; Jeon, Yoon Kyung.
Afiliación
  • Kim S; Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Nam SJ; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Park C; Department of Pathology, Asan Medical Center, Seoul, Republic of Korea.
  • Kwon D; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yim J; Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Song SG; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Ock CY; Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim YA; Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park SH; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim TM; Department of Pathology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul Republic of Korea.
  • Jeon YK; Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Oncoimmunology ; 8(9): e1626653, 2019.
Article en En | MEDLINE | ID: mdl-31428525

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Año: 2019 Tipo del documento: Article